NCT04681872View on ClinicalTrials.gov

Marshall Ethanolization, Pulmonary Vein Isolation and Line Completion for Ablation of Persistent Atrial Fibrillation

NAActive, not recruitingINTERVENTIONAL
Enrollment

262

Participants

Timeline

Start Date

September 20, 2021

Primary Completion Date

September 20, 2027

Study Completion Date

September 20, 2027

Conditions
Atrial Fibrillation
Interventions
PROCEDURE

Destruction of Marshall bundles

Destruction of Marshall bundles by ethanol 96% infusion (2 separate injections of 5ml on 1 minute each) followed by ablation of the distal coronary sinus bundles, the ridge and the saddle.

PROCEDURE

Pulmonary veins isolation

Achievement of a wide disconnection of the right and left pulmonary veins.

PROCEDURE

Linear ablation in the left and right atria

Ablation of the mitral, the roof, and the cavo-tricuspid isthmus

Trial Locations (9)

8000

AZ Sint Jan Brugge, Bruges

30032

Les Franciscaines Hospital, Nîmes

31076

Clinique Pasteur, Toulouse

31400

Toulouse University Hospirtal, Toulouse

33074

Clinique Saint Augustin, Bordeaux

33604

Bordeaux University Hospital, Pessac

63003

Clermont-Ferrand University Hospital, Clermont-Ferrand

92200

Ambroise Paré Hospital, Neuilly-sur-Seine

93200

Centre Cardiologique du Nord, Saint-Denis

All Listed Sponsors
lead

University Hospital, Bordeaux

OTHER